Police found supplies of cocaine, cannabis, Valium and pregabalin - and a stash of amphetamine in the microwave ...

US President Donald Trump plans to impose a 200 percent tariff on imported medicines to push drug companies into cutting ...

Americans cannot absorb billions in added drug price hikes as a result of ill-designed and poorly timed tariff increases.

Otsuka Pharmaceutical Co.’s medicine for post-traumatic stress disorder with partner H. Lundbeck A/S failed to win the backing of US regulatory advisers, a major setback in the drugmakers’ bid to ...

Detailed price information for 60 Degrees Pharmaceuticals Inc (SXTP-Q) from The Globe and Mail including charting and trades.

New Drug Application intended for 2026, subject to generation of positive data from three U.S. clinical trials planned or in progressTotal addressable market (TAM) for ARAKODA for Human Babesiosis is ...

No opening of the cranium, no cutting into the brain, no blood. Today's precise psychosurgery presents options for patients ...

Detailed price information for 60 Degrees Pharmaceuticals Inc (SXTP-Q) from The Globe and Mail including charting and trades.

Dr. Evan Chavers and Dr. Shyla Hossain from Accordia Health appeared on WKRG News 5’s The Doctor is In to discuss schizophrenia and available treatment options.

Neumora initiates Phase 1 study for NMRA-861, a potential treatment for schizophrenia with promising pharmacological profile.

Submission is based on long-term Phase 3 data demonstrating 63 percent reduction in risk of relapse in adults with schizophrenia compared to placebo CAPLYTA® is FDA approved to treat schizophrenia and ...